Harry Sacks

MedicineDentistryImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “CLINICAL EFFICACY OF DUPILUMAB TREATMENT DURING WITHDRAWAL OF INHALED CORTICOSTEROIDS/LONG-ACTING BETA AGONISTS”.

CLINICAL EFFICACY OF DUPILUMAB TREATMENT DURING WITHDRAWAL OF INHALED CORTICOSTEROIDS/LONG-ACTING BETA AGONISTS

CHEST Journal(2024)10.1016/j.chest.2024.06.2860

N/A

0DataRank · unranked

0 citations

David S. Jackson, KLAUS F RABE, Ian Pavord, J. Christian Virchow, Rohit Katial +9 more

BASELINE CHARACTERISTICS OF PATIENTS ON MEDIUM- VS HIGH-DOSE INHALED CORTICOSTEROIDS IN PATIENTS INITIATING DUPILUMAB IN A REAL-WORLD CLINICAL SETTING: THE RAPID REGISTRY

CHEST Journal(2024)10.1016/j.chest.2024.06.2843

N/A

0DataRank · unranked

0 citations

Andréanne Côté, Arnaud Bourdin, ANJU T PETERS, LEONARD B BACHARIER, Changming Xia +7 more

Transient early blood eosinophil increases do not affect dupilumab’s long-term efficacy in patients with moderate-to-severe asthma

Journal of Allergy and Clinical Immunology(2025)10.1016/j.jaci.2025.07.037

N/A

0DataRank · unranked

1 citations

Njira Lugogo, Mario Castro, Alberto Papi, Arnaud Bourdin, Michael E. Wechsler +8 more